What is the treatment for white patches on a child's face, possibly due to conditions like pityriasis versicolor, vitiligo, or eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

White Patches on a Child's Face: Diagnostic and Treatment Approach

Initial Diagnostic Evaluation

The diagnosis of white patches on a child's face should be based on clinical examination with Wood's light evaluation, which is particularly useful in fair-skinned patients, and serial photographs to monitor changes over time. 1

The most common causes of white patches on children's faces include:

  • Pityriasis alba - the most common cause, presenting as hypopigmented patches often with fine scale, typically in atopic children 2, 1
  • Tinea versicolor (pityriasis versicolor) - hypopigmented or hyperpigmented scaly patches, more common in warm climates 3, 4, 5
  • Vitiligo - well-demarcated depigmented (not hypopigmented) patches with symmetrical distribution 2, 1
  • Atopic dermatitis - may present with associated hypopigmentation, pruritus, and typical eczematous features 2

Key Diagnostic Features

  • Visual inspection and palpation should assess for scale, texture, and distribution patterns 1
  • Wood's light examination enhances visualization of hypopigmented lesions, especially in lighter skin types 1, 6
  • Dermoscopy can aid in clinical assessment 1
  • For multiple hypopigmented macules with irregular borders, early referral to pediatric dermatology is recommended 1
  • For solitary small or medium lesions without concerning features, referral can be delayed or managed in primary care 1

Treatment Based on Specific Diagnosis

Pityriasis Alba

Bland emollients applied regularly are the primary treatment to address xerosis and reduce itching in children with pityriasis alba. 1

  • This condition is self-limited and often requires only reassurance and moisturization 1
  • The hypopigmentation typically resolves gradually over months to years 2

Tinea Versicolor (Pityriasis Versicolor)

Topical treatments should be the first-line therapeutic option in children due to their favorable safety profile. 3

  • Ketoconazole cream 2% applied once daily for two weeks is FDA-approved and effective 4
  • Ketoconazole shampoo can be used as an alternative topical option 7
  • Selenium sulfide and zinc pyrithione shampoo are additional topical alternatives 7
  • Treatment duration is typically two weeks for tinea versicolor 4
  • Proper cleaning of combs and brushes is essential to avoid reinfection 3
  • Prophylactic treatment regimens may be necessary to prevent recurrence 7

Vitiligo

For children with vitiligo, topical calcineurin inhibitors are preferred over potent steroids for safety reasons. 1

Initial Management Steps:

  • Perform thyroid function tests, including anti-thyroglobulin antibodies, due to high prevalence of autoimmune thyroid disease 1, 6
  • Document extent with serial photographs for monitoring progression 1, 6
  • Assessment of skin type is useful in initial examination 6

Treatment Options:

  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are preferred in children under 18 years 1
  • If topical steroids are used, limit potent or very potent formulations to no more than 2 months due to risk of skin atrophy 2, 1
  • Narrowband UVB phototherapy should be reserved for widespread disease or significant quality of life impact, monitored with serial photographs every 2-3 months 2, 1
  • Safety limits for NB-UVB are more stringent than for psoriasis, with an arbitrary limit of 200 treatments for skin types I-III 2
  • Oral corticosteroids should be avoided due to unacceptable risk of side-effects in children 2, 1

Special Considerations:

  • For children with skin types I-II and limited disease, camouflage cosmetics and sunscreens may be appropriate initial management without active treatment 2, 1
  • Psychological assessment and support should be offered to children and parents, as pigmentation disorders can significantly impact quality of life 2, 1

Atopic Dermatitis with Hypopigmentation

Diagnosis should be based on essential features: pruritus, typical eczematous morphology with age-specific patterns, and chronic or relapsing history. 2

  • Pityriasis alba is listed as an associated feature of atopic dermatitis 2
  • Treatment follows standard atopic dermatitis management with topical emollients and appropriate anti-inflammatory therapy 2

Common Pitfalls to Avoid

  • Do not use potent topical steroids on the face for extended periods - limit to 2 months maximum to prevent skin atrophy 2, 1
  • Do not prescribe oral corticosteroids for vitiligo in children - unacceptable side-effect profile 2, 1
  • Do not overlook thyroid screening in vitiligo patients - autoimmune thyroid disease is common 1, 6
  • Do not forget to address psychological impact - white patches on the face can significantly affect quality of life in children 2, 1
  • Ensure proper follow-up for tinea versicolor - recurrence is common without prophylactic measures 3, 7

References

Guideline

Diagnostic Approach to Hypopigmented Lesions in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Pitiriasis Versicolor in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Pityriasis versicolor in children: a retrospective study of 164 cases].

Annales de dermatologie et de venereologie, 1998

Guideline

Initial Laboratory Workup for Pediatric Vitiligo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of seborrheic dermatitis and pityriasis versicolor.

American journal of clinical dermatology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.